Background: Migraine is costly to governments.
Despite significant burden, Canada lacks population data regarding migraine
prevalence, resource and medication utilization. We sought to characterize
the demographics, health resource utilization, and medication use in an
adult migraine cohort in Alberta. Methods: Migraine
cohort: previously validated case definition of migraine (ICD 10 +
dispensation of abortive and/or preventative migraine drug
(04/2010-03/2016). Patients over 18 years, followed three years from index
date [first dispensation of migraine medication]. Health resource
utilization (HRU) assessed by emergency department (ED) visits, hospital
admission and physician claims. Medication assessed province-wide
dispensation database linkage. Patient demographics and Charlson Comorbidity
Index (CCI) included. Results: Over 5 years: 53,333
migraine cases identified (mean age 40.5 years, 79% female). Common
comorbidities: hypertension, COPD, diabetes mellitus, cancer,
cerebrovascular disease. Mean CCI 0.55 (SD 1.06). Metropolitan patients:
48%, urban 34.6%, rural 17.4%. Initial migraine diagnosis: 46% by GP, 31% in
ED. Rural patients present more to ED/hospital for care in 3-year follow-up
(IRR 2.95 [2.83, 3.08]). Conclusions: Our migraine
case definition is more specific than sensitive and underestimates Alberta’s
migraine prevalence. Higher female prevalence as expected. Rurally, migraine
care largely occurs in ED/hospital. Study of prevalence, HRU and medications
may help inform health policy in Alberta and Canada.